
Acer Therapeutics Inc.
USD0.66
-0.14 (-17.95%)
CEO
Christopher Schelling
IPO Date
2004-04-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.80
Prev. Close
$0.80
Day Low
$0.66
Day High
$0.85
52W Low
$0.55
52W High
$4.56
Volume
0.57M
| 1 Sept 2023 |
| Roth MKM |
| Buy |
| Neutral |
| downgrade |
| 31 Aug 2023 | Roth Capital | Buy | Neutral | downgrade |
| 31 Aug 2023 | Roth MKM | Buy | Neutral | downgrade |
| 28 Mar 2023 | HC Wainwright & Co. | Buy | Buy | maintain |
| 20 Mar 2023 | EF Hutton | Buy | Buy | maintain |
| 2 Feb 2022 | EF Hutton | Buy | Buy | maintain |
| 25 Jun 2019 | Needham | Buy | Hold | downgrade |